PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50123C00013 — ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND B…

ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND B… is a federal NONE award for Department of Health and Human Services (HHS) held by APTITUDE MEDICAL SYSTEMS, INC.. Estimated value $33.8M ($33.8M obligated). Current period of performance ends May 14, 2027 (potential Jul 15, 2027). Last award drew 1 bidder.

$33.8M
Estimated Value
May 14, 2027
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

APTITUDE MEDICAL SYSTEMS, INC. holds $14.2M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the May 14, 2027 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50123C00013
AgencyDepartment of Health and Human Services (HHS)
IncumbentAPTITUDE MEDICAL SYSTEMS, INC.
UEINWWEFYLD9JC3
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13
PoP end (current)May 14, 2027
PoP end (w/ options)Jul 15, 2027
Obligated$33.8M

ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND BEYOND

Recompete timing

Public
Expiring in 270 days

Current PoP ends May 14, 2027 (270 days remaining). Agencies typically plan 12–18 months ahead — at 8.9 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

APTITUDE MEDICAL SYSTEMS, INC.$14.2M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$14.2M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75A50123C00013
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open APTITUDE MEDICAL SYSTEMS, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50123C00013?

75A50123C00013 (ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND B…) is a Department of Health and Human Services (HHS) award with an estimated value of $33.8M, currently held by APTITUDE MEDICAL SYSTEMS, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50123C00013?

APTITUDE MEDICAL SYSTEMS, INC. is the incumbent with $14.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends May 14, 2027.

When does 75A50123C00013 come up for recompete?

SCOUT tracks a period-of-performance end of May 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50123C00013